Use of gelatin hemostatic matrices in patients with intraparenchymal hemorrhage and drug-induced coagulopathy.
In the routine practice of neurosurgery, the attainment of appropriate hemostasis during and after surgery is of the utmost importance. In the last few years, we have noticed that in several cases the standard coagulation methods (bipolar, Tabotamp, Spongostan) were not sufficient; in particular, patients with intraparenchymal hemorrhage under anticoagulant or antiplatelet therapy were observed to be the most difficult hemostasis cases, and thus those most frequently subjected to gelatin hemostatic matrices. We report our trial on 57 patients under anticoagulant or antiplatelet therapy and with intraparenchymal hemorrhage in which gelatin hemostatic matrices were used. The excellent results both in terms of outcome and decreased bleeding allow for regarding such a practice as safe and reproducible in these cases.
Department of Neurosurgery, Ospedale dell'Angelo, Mestre, Venice, Italy - j.delverme@libero.it.
Jacopo
J
Del Verme
Department of Neurosurgery, Ospedale dell'Angelo, Mestre, Venice, Italy.
Carlo
C
Conti
Department of Neurosurgery, Ospedale dell'Angelo, Mestre, Venice, Italy.
Franco
F
Guida
D000328:Adult; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000601:surgery; D005260:Female; D005780:Gelatin / Q000494:pharmacology*; D006470:Hemorrhage / Q000601:surgery*; D006490:Hemostatics / Q000378:metabolism*; D006801:Humans; D008297:Male; D009493:Neurosurgery / Q000379:methods
D006490:Hemostatics; D005780:Gelatin